KNSA
Kiniksa Pharmaceuticals Ltd
78.00$
+1.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.3% | 5.2% | 5.0% | 4.8% | -2.0% | 15.3% | 16.2% | 17.9% | 18.6% | 26.7% | 23.4% | 19.5% | 22.0% | |
| 0.9% | 0.3% | 0.6% | 0.4% | 0.4% | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% | 0.8% | 0.2% | 0.4% | |
| 10.1% | 9.3% | 9.0% | 6.8% | 7.0% | 6.8% | 5.6% | 5.7% | 5.6% | 1.9% | 4.7% | 4.8% | 4.3% | |
| 28.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 16.4% | -4.7% | 10.7% | -9.1% | 5.0% | 16.8% | 1.2% | -1.1% | -0.6% | 9.6% | 4.8% | -4.1% | 2.2% | |
| 0.0% | 0.1% | 0.1% | 0.0% | 0.0% | 0.2% | 0.1% | 0.1% | 0.4% | 0.3% | 0.1% | 0.3% | 0.3% | |
| -18.3% | -17.9% | 32.0% | -43.1% | -5.7% | 53.3% | -37.4% | -2.5% | -34.7% | -35.0% | -14.9% | -30.2% | -28.4% | |
| -1.6% | -0.3% | -0.5% | -1.2% | -2.4% | -0.5% | -0.3% | -1.3% | -2.4% | -0.5% | -0.1% | 0.1% | -0.6% | |
| 0.8% | 0.8% | 4.5% | -0.2% | 6.0% | 1.7% | 2.0% | 6.8% | 6.6% | 3.8% | 2.8% | 2.5% | 3.8% | |
| 7.8% | -11.8% | 41.5% | -38.5% | -1.7% | 70.4% | -19.2% | 22.3% | -9.5% | -4.6% | 11.4% | -8.2% | -2.6% | |
| 25.3% | 5.1% | 4.9% | 4.8% | -2.0% | 15.2% | 16.1% | 17.8% | 18.2% | 26.4% | 23.4% | 19.2% | 21.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.